-5%
Sulprex Inhalation Aerosol is prescribed for patients with chronic obstructive pulmonary disease (COPD) who are already using a regular inhaled bronchodilator but continue to experience signs of bronchospasm. It is intended for individuals who require an additional bronchodilator to achieve better control of symptoms.
- Use cautiously in patients with narrow-angle glaucoma, prostatic enlargement, or bladder-neck obstruction (due to Ipratropium).
- Use cautiously in those with seizure disorders, hyperthyroidism, diabetes, or unusual sensitivity to sympathomimetic drugs (due to Salbutamol).
Sulprex is a combination inhalation aerosol containing two active ingredients:
- Salbutamol (as sulphate) – a short-acting β₂-adrenergic bronchodilator that relaxes bronchial smooth muscle and improves airflow.
- Ipratropium bromide – an anticholinergic bronchodilator that inhibits the muscarinic action of acetylcholine on bronchial smooth muscle, thereby preventing an increase in intracellular cyclic GMP.
Together, they provide bronchodilation via two distinct mechanisms:
Anticholinergic (parasympatholytic) action from Ipratropium bromide.
Sympathomimetic action from Salbutamol.
This combination often results in greater and more sustained relief from bronchospasm compared to using either drug alone at standard doses.
The product uses HFA (hydrofluoroalkane) as an eco-friendly propellant instead of CFCs (chlorofluorocarbons), which are harmful to the ozone layer.